Closed
The Marked Chart Wire · Business
Vertex
Vertex Pharmaceuticals projects 2026 revenue between $13.15 billion and $13.25 billion. The guidance includes $40 million to $50 million from Crinetics.
Prices from Before the open · based on Mon close · Opens 9:30 AM ET. Each tile opens the stock's chart and news.
New to this? Read: Reading a stock chart
Vertex Pharmaceuticals
Vertex Pharmaceuticals reported third-quarter revenue of $3.43 billion, matching expectations. Earnings per share came in at $4.76, slightly below the expected $4.78.
Palantir
Palantir posted $2.3 billion in sales for the third quarter, marking a 96 percent jump from the prior-year period.
BioMarin
BioMarin projects full-year 2026 revenue between $3.8 billion and $3.9 billion. The company also noted $70 million in order deferrals.
HotGrab Earnings
Grab Holdings reported that third-quarter revenue increased by 27 percent. The company also raised its financial guidance, causing the stock to move in after-hours trading.
HotGrab
Grab released its third quarter earnings, describing the performance as mixed. The company also increased its full year 2026 financial outlook.
Match Group
Match Group indicated that margins would face a 1 percent headwind in 2027. The company noted that daily active users on its Tinder platform have returned to positive growth.
Fast headlines, summarized. Not verified and not advice. Check the full story before you act.